Ana Herranz

Contable-Asistente financiero at Highlight Therapeutics SL - , ,

Ana Herranz's Contact Details
HQ
Location
Madrid,Community of Madrid,Spain
Company
Highlight Therapeutics SL
Ana Herranz's Company Details
Highlight Therapeutics SL logo, Highlight Therapeutics SL contact details

Highlight Therapeutics SL

, , • 1 - 10 Employees
Biotechnology

Highlight, formerly known as Bioncotech Therapeutics S.L, is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology. Its lead drug candidate BO-112 is a best-in-class RNA-based therapy which has been demonstrated to initiate a powerful immune response, leveraging a unique multi-target approach to turn ‘cold' tumors ‘hot' and therefore visible to the immune system. It has the potential to rescue patients who are resistant to current checkpoint inhibitor therapy. BO-112 is currently being investigated in a range of clinical trials as a monotherapy and in combination with checkpoint inhibitors. In addition to in-house research, Highlight Therapeutics has a number of external collaborators, including Merck & Co and UCLA.

Details about Highlight Therapeutics SL
Frequently Asked Questions about Ana Herranz
Ana Herranz currently works for Highlight Therapeutics SL.
Ana Herranz's role at Highlight Therapeutics SL is Contable-Asistente financiero.
Ana Herranz's email address is ***@highlighttherapeutics.com. To view Ana Herranz's full email address, please signup to ConnectPlex.
Ana Herranz works in the Research industry.
Ana Herranz's colleagues at Highlight Therapeutics SL are Elena Castellote, Santiago Vega, Juan Quesada, Arianne Munoz, Javier Lopez, Isabel Melendres, Idoia Herrero and others.
Ana Herranz's phone number is
See more information about Ana Herranz